Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients.

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1997 • 3,167 citations

Oncogenes and signal transduction

1991 • 2,816 citations

X-linked IAP is a direct inhibitor of cell-death proteases

1997 • 1,961 citations

The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases

1997 • 1,316 citations

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.

1998 • 1,243 citations

Human neoplasms elicit multiple specific immune responses in the autologous host.

1995 • 1,097 citations

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1998 • 985 citations

Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.

1998 • 720 citations

Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation.

1998 • 512 citations

Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas.

1998 • 473 citations

Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

1994 • 213 citations

A Novel Cytoplasmic Protein with RNA-binding Motifs Is an Autoantigen in Human Hepatocellular Carcinoma

1999 • 200 citations

Immunity to Oncogenic Proteins

1995 • 180 citations

p53 antibodies in patients with various types of cancer: assay, identification, and characterization.

1995 • 134 citations

Comparison of the Diagnostic Accuracy of Three Commercially Available Enzyme Immunoassays for Anti-p53 Antibodies

1999 • 12 citations